Nuo Therapeutics, Inc. (AURX)
OTCMKTS
· Delayed Price · Currency is USD
1.533
-0.018 (-1.13%)
Dec 24, 2024, 4:00 PM EST
Nuo Therapeutics Revenue
Nuo Therapeutics had revenue of $370.95K in the quarter ending September 30, 2024, with 59.73% growth. This brings the company's revenue in the last twelve months to $1.17M, up 140.43% year-over-year. In the year 2023, Nuo Therapeutics had annual revenue of $608.53K with 442.12% growth.
Revenue (ttm)
1.17M
Revenue Growth
+140.43%
P/S Ratio
58.12
Revenue / Employee
129.70K
Employees
9
Market Cap
71.75M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.66B |
Ryman Healthcare Limited | 458.44M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals Inc. | 104.76M |
Nuo Therapeutics News
- 1 year ago - Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange - GlobeNewsWire
- 1 year ago - Nuo Therapeutics' Aurix® System Added To Wound Care Formulary Of Wound Care Advantage - GlobeNewsWire
- 2 years ago - Nuo Therapeutics Provides Corporate and Business Update - GlobeNewsWire